Show simple item record

dc.contributor.authorKatz, Erica L.
dc.contributor.authorHarris, John E.
dc.date2022-08-11T08:09:59.000
dc.date.accessioned2022-08-23T16:51:20Z
dc.date.available2022-08-23T16:51:20Z
dc.date.issued2021-03-02
dc.date.submitted2021-06-14
dc.identifier.citation<p>Katz EL, Harris JE. Translational Research in Vitiligo. Front Immunol. 2021 Mar 2;12:624517. doi: 10.3389/fimmu.2021.624517. PMID: 33737930; PMCID: PMC7962476. <a href="https://doi.org/10.3389/fimmu.2021.624517">Link to article on publisher's site</a></p>
dc.identifier.issn1664-3224 (Linking)
dc.identifier.doi10.3389/fimmu.2021.624517
dc.identifier.pmid33737930
dc.identifier.urihttp://hdl.handle.net/20.500.14038/41836
dc.description.abstractVitiligo is a disease of the skin characterized by the appearance of white spots. Significant progress has been made in understanding vitiligo pathogenesis over the past 30 years, but only through perseverance, collaboration, and open-minded discussion. Early hypotheses considered roles for innervation, microvascular anomalies, oxidative stress, defects in melanocyte adhesion, autoimmunity, somatic mosaicism, and genetics. Because theories about pathogenesis drive experimental design, focus, and even therapeutic approach, it is important to consider their impact on our current understanding about vitiligo. Animal models allow researchers to perform mechanistic studies, and the development of improved patient sample collection methods provides a platform for translational studies in vitiligo that can also be applied to understand other autoimmune diseases that are more difficult to study in human samples. Here we discuss the history of vitiligo translational research, recent advances, and their implications for new treatment approaches.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=33737930&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © 2021 Katz and Harris. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectautoimmunity
dc.subjectgenetics
dc.subjectmelanocyte oxidative stress
dc.subjecttranslational research
dc.subjectvitiligo
dc.subjectDermatology
dc.subjectImmune System Diseases
dc.subjectImmunopathology
dc.subjectSkin and Connective Tissue Diseases
dc.subjectTranslational Medical Research
dc.titleTranslational Research in Vitiligo
dc.typeJournal Article
dc.source.journaltitleFrontiers in immunology
dc.source.volume12
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5668&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/4637
dc.identifier.contextkey23344508
refterms.dateFOA2022-08-23T16:51:20Z
html.description.abstract<p>Vitiligo is a disease of the skin characterized by the appearance of white spots. Significant progress has been made in understanding vitiligo pathogenesis over the past 30 years, but only through perseverance, collaboration, and open-minded discussion. Early hypotheses considered roles for innervation, microvascular anomalies, oxidative stress, defects in melanocyte adhesion, autoimmunity, somatic mosaicism, and genetics. Because theories about pathogenesis drive experimental design, focus, and even therapeutic approach, it is important to consider their impact on our current understanding about vitiligo. Animal models allow researchers to perform mechanistic studies, and the development of improved patient sample collection methods provides a platform for translational studies in vitiligo that can also be applied to understand other autoimmune diseases that are more difficult to study in human samples. Here we discuss the history of vitiligo translational research, recent advances, and their implications for new treatment approaches.</p>
dc.identifier.submissionpathoapubs/4637
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.contributor.departmentDepartment of Medicine, Division of Dermatology
dc.source.pages624517


Files in this item

Thumbnail
Name:
fimmu_12_624517.pdf
Size:
1.675Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright © 2021 Katz and Harris. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Except where otherwise noted, this item's license is described as Copyright © 2021 Katz and Harris. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.